Cohance Lifesciences Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -429.50 +6.30 (1.49%)Updated : 18 May 2026
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 5,729.64 | 5,480.96 | 2,254.09 | 1,965.74 |
| Cash Equivalents | 10.52 | 5.83 | 0.00 | - |
| Other Liabilities Total | 695.93 | 559.21 | 10.50 | 8.30 |
| Long Term Debt | 50.48 | 129.75 | 0.00 | 4.56 |
| Common Stock Total | 38.26 | 25.46 | 25.46 | 25.46 |
| Other Equity Total | 3,873.03 | 3,623.36 | 0.53 | - |
| Other Current Assets Total | 217.17 | 209.88 | 1.02 | 1.06 |
| Total Assets | 5,729.64 | 5,480.96 | 2,254.09 | 1,965.74 |
| Current Portof LT Debt/ Capital Leases | 144.44 | 165.06 | 43.76 | 20.48 |
| Cash | 49.14 | 96.65 | 47.23 | 64.80 |
| Total Equity | 3,911.29 | 3,648.82 | 2,050.66 | 1,735.18 |
| Long Term Investments | 294.67 | 173.93 | 139.95 | 117.10 |
| Total Common Shares Outstanding | 38.26 | 25.46 | 25.46 | 25.46 |
| Tangible Book Valueper Share Common Eq | 66.08 | 90.49 | 78.12 | 65.72 |
| Goodwill Net | 1,283.65 | 1,238.96 | 60.26 | - |
| Total Liabilities | 1,818.35 | 1,832.14 | 203.42 | 230.56 |
| Total Debt | 400.49 | 485.93 | 65.00 | 70.34 |
| Short Term Investments | 268.13 | 203.85 | 776.15 | 421.09 |
| Cashand Short Term Investments | 327.79 | 306.33 | 823.38 | 485.89 |
| Total Receivables Net | 689.07 | 774.59 | 200.79 | 184.89 |
| Deferred Income Tax | 97.90 | 102.59 | 64.79 | 58.23 |
| Accounts Receivable- Trade Net | 681.01 | 772.10 | 134.09 | 111.22 |
| Property/ Plant/ Equipment Total- Net | 2,163.30 | 2,096.40 | 786.78 | 766.22 |
| Minority Interest | 122.54 | 144.06 | - | - |
| Total Current Liabilities | 645.93 | 705.41 | 106.90 | 158.77 |
| Total Inventory | 562.23 | 467.37 | 233.08 | 330.58 |
| Accounts Payable | 284.58 | 268.43 | 42.36 | 65.16 |
| Other Currentliabilities Total | 216.91 | 271.92 | 20.78 | 28.52 |
| Total Long Term Debt | 256.05 | 320.87 | 21.24 | 5.26 |
| Intangibles Net | 99.52 | 106.35 | 1.67 | 62.19 |
| Other Long Term Assets Total | 51.78 | 53.93 | 2.24 | 5.91 |
| Note Receivable- Long Term | 40.46 | 53.22 | 0.01 | 3.27 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,796.26 | 1,758.17 | 1,263.19 | 1,011.05 |
| Capital Lease Obligations | 205.57 | 191.12 | 21.24 | 0.70 |
| Accumulated Depreciation Total | - | - | -252.13 | -210.10 |
| Prepaid Expenses | - | - | 4.92 | 8.63 |
| Additional Paid- In Capital | - | - | 109.57 | 109.57 |
| Retained Earnings( Accumulated Deficit) | - | - | 1,891.39 | 1,589.44 |
| Property/ Plant/ Equipment Total- Gross | - | - | 859.93 | 811.23 |
| Notes Payable/ Short Term Debt | - | - | 0.00 | 44.60 |
| Unrealized Gain( Loss) | - | - | 23.72 | 10.72 |
*All figures in crores except per share values
Cohance Lifesciences Quick Links
Cohance Lifesciences Dividend Cohance Lifesciences Bonus Cohance Lifesciences News Cohance Lifesciences AGM Cohance Lifesciences Rights Cohance Lifesciences Splits Cohance Lifesciences Board Meetings Cohance Lifesciences Key Metrics Cohance Lifesciences Shareholdings Cohance Lifesciences Profit Loss Cohance Lifesciences Cashflow Cohance Lifesciences Q1 Results Cohance Lifesciences Q2 Results Cohance Lifesciences Q3 Results Cohance Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
362.35+23.50(6.94%)
1,122.90+27.30(2.49%)
1,816.90+43.70(2.46%)
1,337.00-24.75 (-1.82%)
4,055.95-74.25 (-1.80%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.